The impact of aggregation on the biodistribution of hypericin

International Journal of Oncology

Volumn 28, Issue 3, 2006, Pages 655-660

  Van De Putte, Marie ^a   Roskams, Tania ^b   Bormans, Guy ^b   Verbruggen, Alfons ^b   De Witte, Peter A M ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aggregation; Hypericin; Macrophages; Monocytes; Photodynamic therapy; Photosensitizer; Tumors

Indexed keywords

DRUG DERIVATIVE; HYPERICIN; PERYLENE; RADIOSENSITIZING AGENT;

ANIMAL; ARTICLE; C3H MOUSE; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; FEMALE; FLUORESCENCE MICROSCOPY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LUNG; METABOLIC CLEARANCE RATE; METABOLISM; MOUSE; MUSCLE; SKIN; SOLUTION AND SOLUBILITY; SPLEEN; SUSPENSION; TIME; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; INJECTIONS, INTRAVENOUS; LIVER; LUNG; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C3H; MICROSCOPY, FLUORESCENCE; MUSCLES; NEOPLASMS, EXPERIMENTAL; PERYLENE; RADIATION-SENSITIZING AGENTS; SKIN; SOLUTIONS; SPLEEN; SUSPENSIONS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 33645238787     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.3.655     Document Type: Article

References (14)

1. Chen B, Zupko I and De Witte PA: Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy. Int J Oncol 18: 737-742, 2001.
2. Chen B, Roskams T and De Witte PA: Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochem Photobiol 76: 509-513, 2002.
3. Chen B and De Witte PA: Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett 150: 111-117, 2000.
4. Chen B, Xu Y, Roskams T, Delaey E, Agostinis P, Vandenheede JR and De Witte P: Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model. Int J Cancer 93: 275-282, 2001.
5. Bormans G, Huyghe D, Christiaen A, et al: Preparation, analysis and biodistribution in mice of iodine-123 labelled derivatives of hypericin. J Labelled Compd Radiopharm 47: 191-198, 2003.
6. Falk H, Meyer J and Oberreiter M: A convenient semisynthetic route to hypericin. Monatsh Chem 124: 339-341, 1993.
7. Huygens A, Kamuhabwa AR and De Witte PA: Stability of different formulations and ion pairs of hypericin. Eur J Pharm Biopharm 59: 461-468, 2005. (Pubitemid 40342520)
8. Lavie G, Mazur Y, Lavie D and Meruelo D: The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med Res Rev 15: 111-119, 1995.
9. Falk H and Meyer J: On the homo- and heteroassociation of hypericin. Monatsh Chem 125: 753-762, 1994.
10. Konan YN, Gurny R and Allemann E: State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 66: 89-106, 2002. (Pubitemid 34240266)
11. Yamazaki T, Ohta N, Yamazaki I and Song PS: Excited-state properties of hypericin: electronic spectra and fluorescence decay kinetics. J Phys Chem 97: 7870-7875, 1993.
12. Jori G, Reddi E, Cozzani I and Tomio L: Controlled targeting of different subcellular sites by porphyrin in tumour-bearing mice. Br J Cancer 53: 615-621, 1986. (Pubitemid 16114621)
13. Richter AM, Waterfield E, Jain AK, Canaan AJ, Allison BA and Levy JG: Liposomal delivery of a photosensitizer benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol 57: 1000-1006, 1993.
14. Kowalsky RJ and Falen SW: Radiopharmaceuticals. In: Nuclear Pharmacy and Nuclear Medicine. Landis NT (ed.) American Pharmacists Association, Washington, pp561-596, 2004.